StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research note published on Thursday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of NYSE AMPE opened at $0.00 on Thursday. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $7.47. The firm has a 50 day moving average price of $0.02 and a two-hundred day moving average price of $0.43. The stock has a market cap of $2,508.00, a P/E ratio of 0.00 and a beta of 3.67.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.